A comparative study of the IMMULITE and Enzyme Linked Immuno Sorbent Assay for measuring Tumor Marker CA-125 in Ovarian Cancer Patients in Khyber Pakhtunkhwa
Ahmad B, Nawaz S, Ali S, Bashir S, Mehmood N, Gul B. 2015. Level and Evaluation of Tumor Marker CA-125 in Ovarian Cancer Patients, in Khyber Pakhtun khwa. Asian Pac J Cancer Prev 1, 185-189.
Chauhan SC, Kumar D, Jaggi M. 2007. Mucins in ovarian cancer diagnosis and therapy. Journal of Ovarian Research 2-21.
Eagle K, Ledermann JA. 1997. Tumor Markers in Ovarian Malignancies. The Oncologist 2, 324-329.
Gebauer G. 1999. IMMULITE OM_MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors. Anti-cancer res. 19, 2535-2560.
Hiss D. 2011. Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways. Journal of Oncology 2012, p 23.
Hefler LA, Rosen AC, Graf A H, Lahousen M, Klein M, Leodolter S, Reinthaller A, Kainz C, Tempfer CB. 2000. The Clinical Value of Serum Concentrations of Cancer Antigen 125 in Patients with Primary Fallopian Tube Carcinoma. Cancer 89, 1555-1560.
Jankovic M, Tapuskovic B. 2005. Molecular forms and micro-heterogeneity of the oligosaccharide chain of pregnancy- associated antigen. Human Reproduction 20, 2632-2638.
Jiang W, Huang R, Duan C, Fu, L, Xi Y, Yang, Y, Huang, RP. 2013. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. PloS one 8(10), e76795. http://dx.doi.org/10.1371/journal.pone.0076795.
Markman M. 1997. The Role of CA-125 in the Management of Ovarian Cancer. The Oncologist 2, 6-9.
Mor G, Visintin I, Lai Y, Zao H, Schwartz P, Rutherford T, Ward DC. 2005. Serum protein markers for early detection of ovarian cancer. Medical Science 102, 7677-7682.
Moss EL, Hollingworth J, Reynolds TM. 2013. The role of CA-125 in Clinical Practices., Journalof Clinical Pathology 2005, 58, 308-312.
Pitta D, Sarian LO, Barreta A, Campos EA, de Angelo Andrade LL, Fachini AM, Derchain S. 2013. Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses. BMC Cancer, 13, p 423.
Rustin GJ, Marples M, Nelstrop AE, Mahmoudi M, Meyer T. 2001. Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels. Journal of Clinical Oncology 19, 4054-4057.
Robert C, Bast. 2003. Status of Tumor Markers in Ovarian Cancer Screening. Journal of Clinical Oncology. 21, 200-205.
Sarwar S, Siddiqui N, Khokhar RA. 2006. Epithelial Ovarian Cancer at a Cancer Hospital in a Developing Country. Asian Pacific Journal of Cancer Prevention 7, 595-598.
Scholler N, Urban N. 2007. CA-125 in Ovarian Cancer. Biomarkers in Medicine, 1, 513-523.
Thomas CM, Massuger LF, Segers MF, Schijf CP, Doesburg WH, Wobbes T. 1995. Analytical and Clinical Performance of Improved Abbott lMx CA 125 Assay: Comparison with Abbott CA 125 Ria. Clinical Chemistry 41, 211-216.
Vuento MH, Stenman UH, Pirhonen JP, Mäkinen JI, Laippala PJ, Salmi TA. 1997. Significance of a single Ca-125 Assay combined with ultrasound in the early detection of ovarian cancer and Eendometrial cancer. Gynecologic oncology 64, 141-146.
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Azori M. 2008. Diagnostic Marker for Early Detection of Ovarian Cancer, Clinical Cancer Research 14, 1065-1072.
Xing F, Sui H, Wu Y, Wang Y, Wang D, Zhou SF. 2011. Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer. Medical Science Monitor 17, 618-625.
Yin BWT, Lloyd KO. 2001. Molecular cloning of the CA_125 Ovarian Cancer Antigen: Identification AS A NEW MUCIN, MUC1. Journal of Biological and chemical Chronicles 276, 27371-27375.
Zou L, He X, Zhang JW. 2010. The efficacy of YKL-40 and CA-125 as biomarkers for Ephithelial Ovarian Cancer. Brazilian Journal of Medical and Biological Research 12, 1232-1238.
Zhang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W, Zhong XY. 2010. Proteomics and Biomarkers for Ovarian Cancer Diagnosis. Annals of Clinical & Laboratory Science, 40, 218-225.